Roxadin (Testosterone undecanoate)

About Galvany Pharma

Galvany Pharma is a private, commercial-stage UK biotech founded in 2018, operating in the generic drugs sector with a focus on oncology and inflammatory diseases. The company has successfully launched several generic injectable products, such as Roxadin and Haloperidol injection, demonstrating a revenue-generating business model built on cost-effective alternatives and strategic partnerships. Led by an experienced management team with a background in building and selling specialty pharma companies, Galvany is actively expanding its pipeline through business development at major industry events while navigating the competitive and low-margin generic drug landscape.

Therapeutic Areas